Kevin HernSell
Alcon Inc. Ordinary Shares · Transaction Aug 5, 2026 · Filed Sep 1, 2026 · $1,001 to $15,000
XNYS · ALC
-0.26% · -$0.1600 · Vol 330.3K
Live · updated 11:52:06 ET
Alcon Inc. Ordinary Shares
$63.77
Follow $ALC
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ALC by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredThu Oct 1 · last completed session · daily score · 17h old · ALC
MethodologyALC
Alcon Inc. Ordinary Shares
Thu Oct 1 · last completed session · daily score · 17h old
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
48/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 1 · last completed session · daily score · 17h old
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ALC moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Alcon Inc. Ordinary Shares
Listed since
2019
Employees
26K
Country
US
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$64.39
Day high
$64.42
Day low
$63.50
Previous close
$63.94
52W high
$87.18
-26.85% from high
52W low
$62.02
7% of range
Market cap
$30.9B
EPS
$-1.3900
Beta
0.09
Shares out
483.4M
Volume
330.3K
0.21× rel vol
Avg volume
1.6M
VWAP
$63.86
Price history computed in-house
1W
-1.08%
1M
-11.72%
3M
-8.45%
1Y
-15.09%
YTD
-19.08%
SMA 50 $69.58 · below
SMA 200 $73.34 · below
52W position 7%
ALC overview
Related filings and maps
Public disclosures
Congress activity in ALC
Official filing ↗
Alcon Inc. Ordinary Shares · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000
Alcon Inc. Ordinary Shares · Transaction Mar 12, 2026 · Filed Apr 8, 2026 · $1,001 to $15,000
Alcon Inc. Ordinary Shares · Transaction Mar 3, 2025 · Filed Apr 14, 2025 · $1,001 to $15,000
Alcon Inc. Ordinary Shares · Transaction Jun 21, 2024 · Filed Jul 9, 2024 · $1,001 to $15,000
Federal contracts
ALC contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ALC in this window.
Lobbying spend
ALC lobbying filings, year to date.
Registered lobbying filings matched to Alcon Inc. Ordinary Shares.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ALC in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ALC.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.